M O Magnusson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M O Magnusson

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Antimicrobial Agents and Chemotherapy|October 2, 2013

Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairmentB J Brennan, K Wang, S Blotner, et al.

Contributions to Nephrology|January 1, 1987

In vivo renal viability assessment by 31P magnetic resonance spectroscopy in an exteriorized kidney. Transplant modelN T Stowe, W J MacIntyre, K Jojima, et al.

Transplantation Proceedings|March 1, 1981

Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programsW E Braun, D Phillips, D G Vidt, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Antimicrobial Agents and Chemotherapy|October 2, 2013

Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairmentB J Brennan, K Wang, S Blotner, et al.

Contributions to Nephrology|January 1, 1987

In vivo renal viability assessment by 31P magnetic resonance spectroscopy in an exteriorized kidney. Transplant modelN T Stowe, W J MacIntyre, K Jojima, et al.

Transplantation Proceedings|March 1, 1981

Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programsW E Braun, D Phillips, D G Vidt, et al.

Pageof 4